Form 4: Colgate-Palmolive Executive Exercises Stock Options and Sells Shares

Panagiotis Tsourapas, Group President, Europe & Developing Markets at Colgate-Palmolive, exercised stock options and sold shares on August 8, 2024.

Summary

• On August 8, 2024, Panagiotis Tsourapas, a Group President at Colgate-Palmolive, exercised stock options for 14,794 shares of common stock at a price of $72.29 per share.
• The same day, Tsourapas sold 14,794 shares of common stock at a weighted average price of $102.9417, with prices ranging from $102.93 to $103.025.
• A portion of the proceeds from the sale was used to cover the exercise price of the options and related tax withholding.
• Following these transactions, Tsourapas directly owns 5,146 shares of common stock.
• Tsourapas also indirectly owns 4,367 shares through the Issuer's 401(k) Plan Trustee and 69,204 shares through a trust.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock option exercises and share sales, which is neutral in sentiment.

Industry Context

Executive stock option exercises and share sales are common occurrences in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's future performance.

Comparison to Industry Standards

• Executive compensation packages often include stock options to align management's interests with those of shareholders.
• The exercise and sale of shares are typical components of these compensation plans.
• The specific details, such as the exercise price, vesting schedule, and sale price, are unique to the individual and the company's compensation policies.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it involves the sale of shares by an executive.
• The sale is part of the executive's compensation and does not necessarily indicate a change in the company's fundamentals.

Key Dates